Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Hematopoietic growth factors: current knowledge, future prospects.

¹Department of Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

Current Problems in Cancer

|July 1, 1992

Summary

Hematopoietic growth factors, produced via recombinant DNA technology, allow unprecedented control over blood cell production. This review explores their role in oncology and hematologic disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Validation of an AI-enabled exome/transcriptome liquid biopsy platform for early detection, MRD, disease monitoring, and therapy selection for solid tumors.

Scientific reports·2025

Same author

Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Same author

Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Same author

Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

Same author

A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib.

Annals of oncology : official journal of the European Society for Medical Oncology·2013

Same author

Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials.

British journal of cancer·2013

Area of Science:

Hematology
Oncology
Molecular Biology

Background:

Hematopoietic growth factors represent a significant advancement in clinical medicine, particularly in oncology.
Recombinant DNA technology has enabled the large-scale production and application of these factors.
Rapid research progress has yielded new agents and highlighted clinical controversies.

Purpose of the Study:

To summarize current knowledge on hematopoietic growth factor control of blood cell production.
To contextualize these factors within clinical medicine, focusing on oncologic therapeutics and hematologic disorders.
To identify remaining questions and future research directions.

Main Methods:

Review of current scientific literature on hematopoietic growth factors.

Related Experiment Videos

Emphasis on factors influencing myeloid cell growth, differentiation, and activation.

Focus on clinical applications in oncology and primary hematologic disorders.

Main Results:

Hematopoietic growth factors offer systematic in vivo manipulation of human blood cell production.
These factors provide insights into blood cell production mechanisms in health and disease.
Significant progress has been made in understanding their biology and clinical applications.

Conclusions:

Hematopoietic growth factors have revolutionized the management of certain cancers and blood disorders.
Further research is needed to fully elucidate their mechanisms and optimize clinical use.
Defining remaining questions is crucial for advancing the field.